Healthcare Fraud Analytics Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Top Countries — Revenue

USD Million/Billion

Access the full forecast model.

Country-level data · Company profiles · Editable dataset · Analyst consultation included.

Healthcare Fraud Analytics Market Analysis — Presence

Geographical Analysis

Click countries to explore
Loading map…

Regional and Country Analysis

Global Healthcare Fraud Analytics Market Analysis 2026

Region / Country 2021 (A)2025 (A)2033 (P) CAGR
Globalxxxxxxxxxxxx26.7%
North Americaxxxxxxxxxxxxxxxx
United Statesxxxxxxxxxxxxxxxx
Canadaxxxxxxxxxxxxxxxx
Mexicoxxxxxxxxxxxxxxxx
Europexxxxxxxxxxxxxxxx
United Kingdomxxxxxxxxxxxxxxxx
Francexxxxxxxxxxxxxxxx
Germanyxxxxxxxxxxxxxxxx
Italyxxxxxxxxxxxxxxxx
Russiaxxxxxxxxxxxxxxxx
Spainxxxxxxxxxxxxxxxx
Swedenxxxxxxxxxxxxxxxx
Denmarkxxxxxxxxxxxxxxxx
Switzerlandxxxxxxxxxxxxxxxx
Luxembourgxxxxxxxxxxxxxxxx
Rest of Europexxxxxxxxxxxxxxxx
Asia Pacificxxxxxxxxxxxxxxxx
Chinaxxxxxxxxxxxxxxxx
Japanxxxxxxxxxxxxxxxx
South Koreaxxxxxxxxxxxxxxxx
Indiaxxxxxxxxxxxxxxxx
Australiaxxxxxxxxxxxxxxxx
Singaporexxxxxxxxxxxxxxxx
Taiwanxxxxxxxxxxxxxxxx
South East Asiaxxxxxxxxxxxxxxxx
Rest of APACxxxxxxxxxxxxxxxx
South Americaxxxxxxxxxxxxxxxx
Brazilxxxxxxxxxxxxxxxx
Argentinaxxxxxxxxxxxxxxxx
Colombiaxxxxxxxxxxxxxxxx
Peruxxxxxxxxxxxxxxxx
Chilexxxxxxxxxxxxxxxx
Rest of South Americaxxxxxxxxxxxxxxxx
Middle Eastxxxxxxxxxxxxxxxx
Saudi Arabiaxxxxxxxxxxxxxxxx
Turkeyxxxxxxxxxxxxxxxx
UAExxxxxxxxxxxxxxxx
Egyptxxxxxxxxxxxxxxxx
Qatarxxxxxxxxxxxxxxxx
Rest of Middle Eastxxxxxxxxxxxxxxxx
Africaxxxxxxxxxxxxxxxx
East Africaxxxxxxxxxxxxxxxx
West Africaxxxxxxxxxxxxxxxx
North Africaxxxxxxxxxxxxxxxx
South Africaxxxxxxxxxxxxxxxx

A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.

Unlock full regional dataset →

Segmentation Analysis

Healthcare Fraud Analytics Market Solution Type Segment Analysis According to cognitive market research, descriptive analytics is the dominant category because it summarizes past data in order to find patterns and trends, which in turn gives vital information. Healthcare businesses can improve their detection tactics by understanding historical fraud incidents and the environment around them, which is helped by this category. Healthcare providers and insurers can use descriptive analytics to combat fraud by identifying patterns and outliers in data and making more educated decisions. < /p>

Descriptive Analytics Healthcare Fraud Analytics Market Analysis
XX
Descriptive Analytics Market Size 2025
XX %
CAGR
Locked · Full data in paid report
Predictive Analytics Healthcare Fraud Analytics Market Analysis
XX
Predictive Analytics Market Size 2025
XX %
CAGR
Locked · Full data in paid report
Prescriptive Analytics Healthcare Fraud Analytics Market Analysis
XX
Prescriptive Analytics Market Size 2025
XX %
CAGR
Locked · Full data in paid report

Market size by (Illustrative, 2025)
Share distribution (2025)

Disclaimer: The charts and graphs are for illustrative purposes only and do not represent actual market values. To access accurate quantitative data, please request a paid report or request free sample.

To learn more about market share and segmentation, request the free sample pages.

Competitor Analysis

In June 2024, HCLTech, a top global tech company, and Tecnotree, a top telecom business support system (BSS) platform provider, announced they would work together to create cutting-edge 5G-based generative AI (GenAI) solutions for the telecom market around the world.

(Source:https://www.hcltech.com/press-releases/hcltech-and-tecnotree-collaborate-bring-5g-led-genai-solutions-telcos)

Click any bar or cell to request the full company profile
Top Companies (In no particular order)2022 (A)2023 (A)2024 (A)2025 (A)
IBM Corporation (US)••• ••• ••• •••
Optum••• ••• ••• •••
Inc. (US)••• ••• ••• •••
Cotiviti••• ••• ••• •••
Inc. (US)••• ••• ••• •••
Change Healthcare (US)••• ••• ••• •••
Fair Isaac Corporation (US)••• ••• ••• •••
SAS Institute Inc. (US)••• ••• ••• •••
EXLService Holdings••• ••• ••• •••
Inc. (US)••• ••• ••• •••
Wipro Limited (India)••• ••• ••• •••
Conduent••• ••• ••• •••
Incorporated (US)••• ••• ••• •••
CGI Inc. (Canada)••• ••• ••• •••
HCL Technologies Limited (India)••• ••• ••• •••
Qlarant••• ••• ••• •••
Inc. (US)••• ••• ••• •••
DXC Technology (US)••• ••• ••• •••
Northrop Grumman Corporation (US)••• ••• ••• •••
LexisNexis (US)••• ••• ••• •••
Healthcare Fraud Shield (US)••• ••• ••• •••
Sharecare••• ••• ••• •••
Inc. (US)••• ••• ••• •••
FraudLens••• ••• ••• •••
Inc. (US)••• ••• ••• •••
HMS Holding Corp. (US)••• ••• ••• •••
Codoxo (US)••• ••• ••• •••
H20.ai (US)••• ••• ••• •••
Pondera Solutions••• ••• ••• •••
Inc. (US)••• ••• ••• •••
FRISS (The Netherlands)••• ••• ••• •••
Multiplan (US)••• ••• ••• •••
FraudScope (US)••• ••• ••• •••
OSP Labs (US)••• ••• ••• •••

We Provide Regional Breakdown of this Companies and Company specific to any Country, Region, Product/ service as well. We cover market share analysis for publicly listed companies as well as privately held companies, subject to data availability.

Request company profile for validation →

Report Scope & Analysis

According to Cognitive Market Research, the global healthcare fraud analytics market size is USD 5.0 billion in 2024 and will expand at a compound annual growth rate (CAGR) of 26.7% from 2024 to 2031.

Introduction of the Healthcare Fraud Analytics Market

Healthcare fraud analytics is the process of identifying and preventing healthcare fraud via the use of data analysis tools and methodologies. The market is expanding because of many factors, including healthcare fraud, more people looking for health insurance, higher returns on investment, and more pharmacy claims scams. However, this market is anticipated to be constrained in its expansion due to the need for more qualified workers. Additionally, the healthcare fraud analytics market is growing because more people want better healthcare services. Moreover, healthcare facilities can better serve their patients, enhance the quality of their services, and decrease the frequency of billing and treatment errors if they are able to reduce fraud. In addition, the market is anticipated to be driven by the rising concern over healthcare expenses and the introduction of improved fraud analytical procedures made possible by technology breakthroughs.

Analyst Conclusion

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Healthcare Fraud Analytics Market Analysis is witnessing significant growth in the near future.

In 2023, the Descriptive Analytics segment accounted for a notable share of the Healthcare Fraud Analytics Market Analysis.

Aarti Bagekari
Aarti Bagekari Verified Analyst
Research Associate at Cognitive Market Research and Consulting
LinkedIn Profile Book a free Consultation

Frequently Asked Questions

Healthcare Fraud Analytics Market Analysis market size and growth rate is provided in the report covering 2021-2025 historical and 2025-2033 forecast data.
Major factors including drivers, restraints, opportunities and challenges are analyzed with detailed insights.
Top manufacturers IBM Corporation (US), Optum, Inc. (US), Cotiviti, Inc. (US), Change Healthcare (US), Fair Isaac Corporation (US), SAS Institute Inc. (US), EXLService Holdings, Inc. (US), Wipro Limited (India), Conduent, Incorporated (US), CGI Inc. (Canada), HCL Technologies Limited (India), Qlarant, Inc. (US), DXC Technology (US), Northrop Grumman Corporation (US), LexisNexis (US), Healthcare Fraud Shield (US), Sharecare, Inc. (US), FraudLens, Inc. (US), HMS Holding Corp. (US), Codoxo (US), H20.ai (US), Pondera Solutions, Inc. (US), FRISS (The Netherlands), Multiplan (US), FraudScope (US), OSP Labs (US) and others are profiled in the report.
Segments include Solution Type, Delivery Model and additional sub-segments.
Regional analysis covers all major markets. The report identifies the dominant region and provides country-level data.
Sample pages can be obtained on demand from the website. 24/7 chat support and direct call services are available.

★ Reviews

Rate this report

Healthcare Fraud Analytics Market Analysis — Table of Contents

Disclaimer:
  • This is just a redacted sample pages of the actual deliverable report and only for representative purposes
  • Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
  • The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
  • Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
  • If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Report Scope
Solution TypeDescriptive Analytics, Predictive Analytics, Prescriptive Analytics
Delivery ModelOn-premise, On-demand
ApplicationInsurance Claims Review, Pharmacy Billing Misuse, Payment Integrity, Others
End-UserPublic & Government Agencies, Private Insurance Payers, Third-party Service Providers, Employers
List of CompetitorsIBM Corporation (US), Optum, Inc. (US), Cotiviti, Inc. (US), Change Healthcare (US), Fair Isaac Corporation (US), SAS Institute Inc. (US), EXLService Holdings, Inc. (US), Wipro Limited (India), Conduent, Incorporated (US), CGI Inc. (Canada), HCL Technologies Limited (India), Qlarant, Inc. (US), DXC Technology (US), Northrop Grumman Corporation (US), LexisNexis (US), Healthcare Fraud Shield (US), Sharecare, Inc. (US), FraudLens, Inc. (US), HMS Holding Corp. (US), Codoxo (US), H20.ai (US), Pondera Solutions, Inc. (US), FRISS (The Netherlands), Multiplan (US), FraudScope (US), OSP Labs (US)

  • Chapter 1. Competitor Analysis (Subject to Data Availability (Private Players))

    • 1.1 Top Competitors Analysis
      • 1.1.1 Global Healthcare Fraud Analytics Market Analysis by Key Players
      • 1.1.2 Segment Market Analysis by Key Players
      • 1.1.3 Top Players Ranking 2024
      • 1.1.4 New Product Launch Analysis
      • 1.1.5 Industry Mergers and Acquisition Analysis
    • 1.2 Company Profile (Data Subject to Availability) Sample Format
      • 1.2.1 IBM Corporation (US)
        • 1.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.1.2 Business Overview
        • 1.2.1.3 Financials (Subject to data availability)
        • 1.2.1.4 R&D Investment (Subject to data availability)
        • 1.2.1.5 Product Types Specification
        • 1.2.1.6 Business Strategy
        • 1.2.1.7 Recent Developments
        • 1.2.1.8 Management Change
        • 1.2.1.9 S.W.O.T Analysis
      • 1.2.2 Optum
        • 1.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.2.2 Business Overview
        • 1.2.2.3 Financials (Subject to data availability)
        • 1.2.2.4 R&D Investment (Subject to data availability)
        • 1.2.2.5 Product Types Specification
        • 1.2.2.6 Business Strategy
        • 1.2.2.7 Recent Developments
        • 1.2.2.8 Management Change
        • 1.2.2.9 S.W.O.T Analysis
      • 1.2.3 Inc. (US)
        • 1.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.3.2 Business Overview
        • 1.2.3.3 Financials (Subject to data availability)
        • 1.2.3.4 R&D Investment (Subject to data availability)
        • 1.2.3.5 Product Types Specification
        • 1.2.3.6 Business Strategy
        • 1.2.3.7 Recent Developments
        • 1.2.3.8 Management Change
        • 1.2.3.9 S.W.O.T Analysis
      • 1.2.4 Cotiviti
        • 1.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.4.2 Business Overview
        • 1.2.4.3 Financials (Subject to data availability)
        • 1.2.4.4 R&D Investment (Subject to data availability)
        • 1.2.4.5 Product Types Specification
        • 1.2.4.6 Business Strategy
        • 1.2.4.7 Recent Developments
        • 1.2.4.8 Management Change
        • 1.2.4.9 S.W.O.T Analysis
      • 1.2.5 Inc. (US)
        • 1.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.5.2 Business Overview
        • 1.2.5.3 Financials (Subject to data availability)
        • 1.2.5.4 R&D Investment (Subject to data availability)
        • 1.2.5.5 Product Types Specification
        • 1.2.5.6 Business Strategy
        • 1.2.5.7 Recent Developments
        • 1.2.5.8 Management Change
        • 1.2.5.9 S.W.O.T Analysis
      • 1.2.6 Change Healthcare (US)
        • 1.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.6.2 Business Overview
        • 1.2.6.3 Financials (Subject to data availability)
        • 1.2.6.4 R&D Investment (Subject to data availability)
        • 1.2.6.5 Product Types Specification
        • 1.2.6.6 Business Strategy
        • 1.2.6.7 Recent Developments
        • 1.2.6.8 Management Change
        • 1.2.6.9 S.W.O.T Analysis
      • 1.2.7 Fair Isaac Corporation (US)
        • 1.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.7.2 Business Overview
        • 1.2.7.3 Financials (Subject to data availability)
        • 1.2.7.4 R&D Investment (Subject to data availability)
        • 1.2.7.5 Product Types Specification
        • 1.2.7.6 Business Strategy
        • 1.2.7.7 Recent Developments
        • 1.2.7.8 Management Change
        • 1.2.7.9 S.W.O.T Analysis
      • 1.2.8 SAS Institute Inc. (US)
        • 1.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.8.2 Business Overview
        • 1.2.8.3 Financials (Subject to data availability)
        • 1.2.8.4 R&D Investment (Subject to data availability)
        • 1.2.8.5 Product Types Specification
        • 1.2.8.6 Business Strategy
        • 1.2.8.7 Recent Developments
        • 1.2.8.8 Management Change
        • 1.2.8.9 S.W.O.T Analysis
      • 1.2.9 EXLService Holdings
        • 1.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.9.2 Business Overview
        • 1.2.9.3 Financials (Subject to data availability)
        • 1.2.9.4 R&D Investment (Subject to data availability)
        • 1.2.9.5 Product Types Specification
        • 1.2.9.6 Business Strategy
        • 1.2.9.7 Recent Developments
        • 1.2.9.8 Management Change
        • 1.2.9.9 S.W.O.T Analysis
      • 1.2.10 Inc. (US)
        • 1.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.10.2 Business Overview
        • 1.2.10.3 Financials (Subject to data availability)
        • 1.2.10.4 R&D Investment (Subject to data availability)
        • 1.2.10.5 Product Types Specification
        • 1.2.10.6 Business Strategy
        • 1.2.10.7 Recent Developments
        • 1.2.10.8 Management Change
        • 1.2.10.9 S.W.O.T Analysis
      • 1.2.11 Wipro Limited (India)
        • 1.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.11.2 Business Overview
        • 1.2.11.3 Financials (Subject to data availability)
        • 1.2.11.4 R&D Investment (Subject to data availability)
        • 1.2.11.5 Product Types Specification
        • 1.2.11.6 Business Strategy
        • 1.2.11.7 Recent Developments
        • 1.2.11.8 Management Change
        • 1.2.11.9 S.W.O.T Analysis
      • 1.2.12 Conduent
        • 1.2.12.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.12.2 Business Overview
        • 1.2.12.3 Financials (Subject to data availability)
        • 1.2.12.4 R&D Investment (Subject to data availability)
        • 1.2.12.5 Product Types Specification
        • 1.2.12.6 Business Strategy
        • 1.2.12.7 Recent Developments
        • 1.2.12.8 Management Change
        • 1.2.12.9 S.W.O.T Analysis
      • 1.2.13 Incorporated (US)
        • 1.2.13.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.13.2 Business Overview
        • 1.2.13.3 Financials (Subject to data availability)
        • 1.2.13.4 R&D Investment (Subject to data availability)
        • 1.2.13.5 Product Types Specification
        • 1.2.13.6 Business Strategy
        • 1.2.13.7 Recent Developments
        • 1.2.13.8 Management Change
        • 1.2.13.9 S.W.O.T Analysis
      • 1.2.14 CGI Inc. (Canada)
        • 1.2.14.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.14.2 Business Overview
        • 1.2.14.3 Financials (Subject to data availability)
        • 1.2.14.4 R&D Investment (Subject to data availability)
        • 1.2.14.5 Product Types Specification
        • 1.2.14.6 Business Strategy
        • 1.2.14.7 Recent Developments
        • 1.2.14.8 Management Change
        • 1.2.14.9 S.W.O.T Analysis
      • 1.2.15 HCL Technologies Limited (India)
        • 1.2.15.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.15.2 Business Overview
        • 1.2.15.3 Financials (Subject to data availability)
        • 1.2.15.4 R&D Investment (Subject to data availability)
        • 1.2.15.5 Product Types Specification
        • 1.2.15.6 Business Strategy
        • 1.2.15.7 Recent Developments
        • 1.2.15.8 Management Change
        • 1.2.15.9 S.W.O.T Analysis
      • 1.2.16 Qlarant
        • 1.2.16.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.16.2 Business Overview
        • 1.2.16.3 Financials (Subject to data availability)
        • 1.2.16.4 R&D Investment (Subject to data availability)
        • 1.2.16.5 Product Types Specification
        • 1.2.16.6 Business Strategy
        • 1.2.16.7 Recent Developments
        • 1.2.16.8 Management Change
        • 1.2.16.9 S.W.O.T Analysis
      • 1.2.17 Inc. (US)
        • 1.2.17.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.17.2 Business Overview
        • 1.2.17.3 Financials (Subject to data availability)
        • 1.2.17.4 R&D Investment (Subject to data availability)
        • 1.2.17.5 Product Types Specification
        • 1.2.17.6 Business Strategy
        • 1.2.17.7 Recent Developments
        • 1.2.17.8 Management Change
        • 1.2.17.9 S.W.O.T Analysis
      • 1.2.18 DXC Technology (US)
        • 1.2.18.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.18.2 Business Overview
        • 1.2.18.3 Financials (Subject to data availability)
        • 1.2.18.4 R&D Investment (Subject to data availability)
        • 1.2.18.5 Product Types Specification
        • 1.2.18.6 Business Strategy
        • 1.2.18.7 Recent Developments
        • 1.2.18.8 Management Change
        • 1.2.18.9 S.W.O.T Analysis
      • 1.2.19 Northrop Grumman Corporation (US)
        • 1.2.19.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.19.2 Business Overview
        • 1.2.19.3 Financials (Subject to data availability)
        • 1.2.19.4 R&D Investment (Subject to data availability)
        • 1.2.19.5 Product Types Specification
        • 1.2.19.6 Business Strategy
        • 1.2.19.7 Recent Developments
        • 1.2.19.8 Management Change
        • 1.2.19.9 S.W.O.T Analysis
      • 1.2.20 LexisNexis (US)
        • 1.2.20.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.20.2 Business Overview
        • 1.2.20.3 Financials (Subject to data availability)
        • 1.2.20.4 R&D Investment (Subject to data availability)
        • 1.2.20.5 Product Types Specification
        • 1.2.20.6 Business Strategy
        • 1.2.20.7 Recent Developments
        • 1.2.20.8 Management Change
        • 1.2.20.9 S.W.O.T Analysis
      • 1.2.21 Healthcare Fraud Shield (US)
        • 1.2.21.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.21.2 Business Overview
        • 1.2.21.3 Financials (Subject to data availability)
        • 1.2.21.4 R&D Investment (Subject to data availability)
        • 1.2.21.5 Product Types Specification
        • 1.2.21.6 Business Strategy
        • 1.2.21.7 Recent Developments
        • 1.2.21.8 Management Change
        • 1.2.21.9 S.W.O.T Analysis
      • 1.2.22 Sharecare
        • 1.2.22.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.22.2 Business Overview
        • 1.2.22.3 Financials (Subject to data availability)
        • 1.2.22.4 R&D Investment (Subject to data availability)
        • 1.2.22.5 Product Types Specification
        • 1.2.22.6 Business Strategy
        • 1.2.22.7 Recent Developments
        • 1.2.22.8 Management Change
        • 1.2.22.9 S.W.O.T Analysis
      • 1.2.23 Inc. (US)
        • 1.2.23.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.23.2 Business Overview
        • 1.2.23.3 Financials (Subject to data availability)
        • 1.2.23.4 R&D Investment (Subject to data availability)
        • 1.2.23.5 Product Types Specification
        • 1.2.23.6 Business Strategy
        • 1.2.23.7 Recent Developments
        • 1.2.23.8 Management Change
        • 1.2.23.9 S.W.O.T Analysis
      • 1.2.24 FraudLens
        • 1.2.24.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.24.2 Business Overview
        • 1.2.24.3 Financials (Subject to data availability)
        • 1.2.24.4 R&D Investment (Subject to data availability)
        • 1.2.24.5 Product Types Specification
        • 1.2.24.6 Business Strategy
        • 1.2.24.7 Recent Developments
        • 1.2.24.8 Management Change
        • 1.2.24.9 S.W.O.T Analysis
      • 1.2.25 Inc. (US)
        • 1.2.25.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.25.2 Business Overview
        • 1.2.25.3 Financials (Subject to data availability)
        • 1.2.25.4 R&D Investment (Subject to data availability)
        • 1.2.25.5 Product Types Specification
        • 1.2.25.6 Business Strategy
        • 1.2.25.7 Recent Developments
        • 1.2.25.8 Management Change
        • 1.2.25.9 S.W.O.T Analysis
      • 1.2.26 HMS Holding Corp. (US)
        • 1.2.26.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.26.2 Business Overview
        • 1.2.26.3 Financials (Subject to data availability)
        • 1.2.26.4 R&D Investment (Subject to data availability)
        • 1.2.26.5 Product Types Specification
        • 1.2.26.6 Business Strategy
        • 1.2.26.7 Recent Developments
        • 1.2.26.8 Management Change
        • 1.2.26.9 S.W.O.T Analysis
      • 1.2.27 Codoxo (US)
        • 1.2.27.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.27.2 Business Overview
        • 1.2.27.3 Financials (Subject to data availability)
        • 1.2.27.4 R&D Investment (Subject to data availability)
        • 1.2.27.5 Product Types Specification
        • 1.2.27.6 Business Strategy
        • 1.2.27.7 Recent Developments
        • 1.2.27.8 Management Change
        • 1.2.27.9 S.W.O.T Analysis
      • 1.2.28 H20.ai (US)
        • 1.2.28.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.28.2 Business Overview
        • 1.2.28.3 Financials (Subject to data availability)
        • 1.2.28.4 R&D Investment (Subject to data availability)
        • 1.2.28.5 Product Types Specification
        • 1.2.28.6 Business Strategy
        • 1.2.28.7 Recent Developments
        • 1.2.28.8 Management Change
        • 1.2.28.9 S.W.O.T Analysis
      • 1.2.29 Pondera Solutions
        • 1.2.29.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.29.2 Business Overview
        • 1.2.29.3 Financials (Subject to data availability)
        • 1.2.29.4 R&D Investment (Subject to data availability)
        • 1.2.29.5 Product Types Specification
        • 1.2.29.6 Business Strategy
        • 1.2.29.7 Recent Developments
        • 1.2.29.8 Management Change
        • 1.2.29.9 S.W.O.T Analysis
      • 1.2.30 Inc. (US)
        • 1.2.30.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.30.2 Business Overview
        • 1.2.30.3 Financials (Subject to data availability)
        • 1.2.30.4 R&D Investment (Subject to data availability)
        • 1.2.30.5 Product Types Specification
        • 1.2.30.6 Business Strategy
        • 1.2.30.7 Recent Developments
        • 1.2.30.8 Management Change
        • 1.2.30.9 S.W.O.T Analysis
      • 1.2.31 FRISS (The Netherlands)
        • 1.2.31.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.31.2 Business Overview
        • 1.2.31.3 Financials (Subject to data availability)
        • 1.2.31.4 R&D Investment (Subject to data availability)
        • 1.2.31.5 Product Types Specification
        • 1.2.31.6 Business Strategy
        • 1.2.31.7 Recent Developments
        • 1.2.31.8 Management Change
        • 1.2.31.9 S.W.O.T Analysis
      • 1.2.32 Multiplan (US)
        • 1.2.32.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.32.2 Business Overview
        • 1.2.32.3 Financials (Subject to data availability)
        • 1.2.32.4 R&D Investment (Subject to data availability)
        • 1.2.32.5 Product Types Specification
        • 1.2.32.6 Business Strategy
        • 1.2.32.7 Recent Developments
        • 1.2.32.8 Management Change
        • 1.2.32.9 S.W.O.T Analysis
      • 1.2.33 FraudScope (US)
        • 1.2.33.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.33.2 Business Overview
        • 1.2.33.3 Financials (Subject to data availability)
        • 1.2.33.4 R&D Investment (Subject to data availability)
        • 1.2.33.5 Product Types Specification
        • 1.2.33.6 Business Strategy
        • 1.2.33.7 Recent Developments
        • 1.2.33.8 Management Change
        • 1.2.33.9 S.W.O.T Analysis
      • 1.2.34 OSP Labs (US)
        • 1.2.34.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.34.2 Business Overview
        • 1.2.34.3 Financials (Subject to data availability)
        • 1.2.34.4 R&D Investment (Subject to data availability)
        • 1.2.34.5 Product Types Specification
        • 1.2.34.6 Business Strategy
        • 1.2.34.7 Recent Developments
        • 1.2.34.8 Management Change
        • 1.2.34.9 S.W.O.T Analysis

  • Chapter 2. Global Healthcare Fraud Analytics Market Analysis

    • 2.1 Global Healthcare Fraud Analytics Market Analysis
    • 2.2 Global Healthcare Fraud Analytics Market Analysis by Region
    • 2.3 Global Healthcare Fraud Analytics Market Analysis by Solution Type
    • 2.4 Global Healthcare Fraud Analytics Market Analysis by Delivery Model
    • 2.5 Global Healthcare Fraud Analytics Market Analysis by Application
    • 2.6 Global Healthcare Fraud Analytics Market Analysis by End-User
    • 2.7 Global Healthcare Fraud Analytics Market Analysis by Key Players

  • Chapter 3. North America Healthcare Fraud Analytics Market Analysis

    • 3.1 North America Healthcare Fraud Analytics Market Analysis
    • 3.2 North America Healthcare Fraud Analytics Market Analysis by Country
    • 3.3 North America Healthcare Fraud Analytics Market Analysis by Solution Type
    • 3.4 North America Healthcare Fraud Analytics Market Analysis by Delivery Model
    • 3.5 North America Healthcare Fraud Analytics Market Analysis by Application
    • 3.6 North America Healthcare Fraud Analytics Market Analysis by End-User
    • 3.7 North America Healthcare Fraud Analytics Market Analysis by Key Players

  • Chapter 4. Europe Healthcare Fraud Analytics Market Analysis

    • 4.1 Europe Healthcare Fraud Analytics Market Analysis
    • 4.2 Europe Healthcare Fraud Analytics Market Analysis by Country
    • 4.3 Europe Healthcare Fraud Analytics Market Analysis by Solution Type
    • 4.4 Europe Healthcare Fraud Analytics Market Analysis by Delivery Model
    • 4.5 Europe Healthcare Fraud Analytics Market Analysis by Application
    • 4.6 Europe Healthcare Fraud Analytics Market Analysis by End-User
    • 4.7 Europe Healthcare Fraud Analytics Market Analysis by Key Players

  • Chapter 5. Asia Pacific Healthcare Fraud Analytics Market Analysis

    • 5.1 Asia Pacific Healthcare Fraud Analytics Market Analysis
    • 5.2 Asia Pacific Healthcare Fraud Analytics Market Analysis by Country
    • 5.3 Asia Pacific Healthcare Fraud Analytics Market Analysis by Solution Type
    • 5.4 Asia Pacific Healthcare Fraud Analytics Market Analysis by Delivery Model
    • 5.5 Asia Pacific Healthcare Fraud Analytics Market Analysis by Application
    • 5.6 Asia Pacific Healthcare Fraud Analytics Market Analysis by End-User
    • 5.7 Asia Pacific Healthcare Fraud Analytics Market Analysis by Key Players

  • Chapter 6. South America Healthcare Fraud Analytics Market Analysis

    • 6.1 South America Healthcare Fraud Analytics Market Analysis
    • 6.2 South America Healthcare Fraud Analytics Market Analysis by Country
    • 6.3 South America Healthcare Fraud Analytics Market Analysis by Solution Type
    • 6.4 South America Healthcare Fraud Analytics Market Analysis by Delivery Model
    • 6.5 South America Healthcare Fraud Analytics Market Analysis by Application
    • 6.6 South America Healthcare Fraud Analytics Market Analysis by End-User
    • 6.7 South America Healthcare Fraud Analytics Market Analysis by Key Players

  • Chapter 7. Middle East Healthcare Fraud Analytics Market Analysis

    • 7.1 Middle East Healthcare Fraud Analytics Market Analysis
    • 7.2 Middle East Healthcare Fraud Analytics Market Analysis by Country
    • 7.3 Middle East Healthcare Fraud Analytics Market Analysis by Solution Type
    • 7.4 Middle East Healthcare Fraud Analytics Market Analysis by Delivery Model
    • 7.5 Middle East Healthcare Fraud Analytics Market Analysis by Application
    • 7.6 Middle East Healthcare Fraud Analytics Market Analysis by End-User
    • 7.7 Middle East Healthcare Fraud Analytics Market Analysis by Key Players

  • Chapter 8. Africa Healthcare Fraud Analytics Market Analysis

    • 8.1 Africa Healthcare Fraud Analytics Market Analysis
    • 8.2 Africa Healthcare Fraud Analytics Market Analysis by Country
    • 8.3 Africa Healthcare Fraud Analytics Market Analysis by Solution Type
    • 8.4 Africa Healthcare Fraud Analytics Market Analysis by Delivery Model
    • 8.5 Africa Healthcare Fraud Analytics Market Analysis by Application
    • 8.6 Africa Healthcare Fraud Analytics Market Analysis by End-User
    • 8.7 Africa Healthcare Fraud Analytics Market Analysis by Key Players

  • Chapter 9. Solution Type Analysis

    • 9.1 Descriptive Analytics
      • 9.1.1 Global Descriptive Analytics Market
      • 9.1.2 Global Descriptive Analytics Market by Region
    • 9.2 Predictive Analytics
      • 9.2.1 Global Predictive Analytics Market
      • 9.2.2 Global Predictive Analytics Market by Region
    • 9.3 Prescriptive Analytics
      • 9.3.1 Global Prescriptive Analytics Market
      • 9.3.2 Global Prescriptive Analytics Market by Region

  • Chapter 10. Delivery Model Analysis

    • 10.1 On-premise
      • 10.1.1 Global On-premise Market
      • 10.1.2 Global On-premise Market by Region
    • 10.2 On-demand
      • 10.2.1 Global On-demand Market
      • 10.2.2 Global On-demand Market by Region

  • Chapter 11. Application Analysis

    • 11.1 Insurance Claims Review
      • 11.1.1 Global Insurance Claims Review Market
      • 11.1.2 Global Insurance Claims Review Market by Region
    • 11.2 Pharmacy Billing Misuse
      • 11.2.1 Global Pharmacy Billing Misuse Market
      • 11.2.2 Global Pharmacy Billing Misuse Market by Region
    • 11.3 Payment Integrity
      • 11.3.1 Global Payment Integrity Market
      • 11.3.2 Global Payment Integrity Market by Region
    • 11.4 Others
      • 11.4.1 Global Others Market
      • 11.4.2 Global Others Market by Region

  • Chapter 12. End-User Analysis

    • 12.1 Public & Government Agencies
      • 12.1.1 Global Public & Government Agencies Market
      • 12.1.2 Global Public & Government Agencies Market by Region
    • 12.2 Private Insurance Payers
      • 12.2.1 Global Private Insurance Payers Market
      • 12.2.2 Global Private Insurance Payers Market by Region
    • 12.3 Third-party Service Providers
      • 12.3.1 Global Third-party Service Providers Market
      • 12.3.2 Global Third-party Service Providers Market by Region
    • 12.4 Employers
      • 12.4.1 Global Employers Market
      • 12.4.2 Global Employers Market by Region

  • Chapter 13. Qualitative Analysis (Subject to Data Availability)

    • 13.1 Market Drivers
    • 13.2 Market Restraints
    • 13.3 Market Trends
    • 13.4 Market Opportunity
    • 13.5 Technological Road Map (Subject to Data Availability)
    • 13.6 Product Life Cycle (Subject to Data Availability)
    • 13.7 Customer and Buyer Behavior Analysis
      • 13.7.1 Digital Engagement, Customer Experience & Relationship Analysis
      • 13.7.2 Customer Buying Behavior & Purchase Decision Analysis
      • 13.7.3 Vendor Selection, Supplier Preferences & Future Demand Trends
      • 13.7.4 Pricing, Affordability & Value Perception Analysis
      • 13.7.5 Customer Segmentation & Demand Pattern Analysis
    • 13.8 PESTEL Analysis
      • 13.8.1 Political Factors
      • 13.8.2 Economic Factors
      • 13.8.3 Social Factors
      • 13.8.4 Technological Factors
      • 13.8.5 Legal Factors
      • 13.8.6 Environmental Factors
    • 13.9 Industrial Chain Analysis (Subject to Data Availability)
      • 13.9.1 Industry Chain Analysis
      • 13.9.2 Manufacturing Cost Analysis
      • 13.9.3 Supply Side Analysis
        • 13.9.3.1 Raw Material Analysis
        • 13.9.3.2 Raw Material Procurement Analysis
        • 13.9.3.3 Raw Material Price Trend Analysis
    • 13.10 Porter’s Five Forces Analysis
      • 13.10.1 Bargaining Power of Suppliers
      • 13.10.2 Bargaining Power of Buyers
      • 13.10.3 Threat of New Entrants
      • 13.10.4 Threat of Substitutes
      • 13.10.5 Degree of Competition
    • 13.11 Patent Analysis (Subject to Data Availability)
    • 13.12 ESG Analysis
    • 13.13 Geopolitical Outlook
      • 13.13.1 Global Power Realignment & Strategic Alliances
      • 13.13.2 Geopolitical Risk Landscape & Conflict Hotspots
      • 13.13.3 International Trade Relations & Market Access Environment
      • 13.13.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
      • 13.13.5 Supply Chain Resilience, Localization & Resource Nationalism
      • 13.13.6 Technology Sovereignty & Digital Geopolitics
      • 13.13.7 Strategic Implications for Investment, Growth & Market Entry
    • 13.14 AI & Market Transformation
      • 13.14.1 Competitive Landscape Disruption & Strategic Shifts
      • 13.14.2 AI-Driven Transformation of Industry Value Chain
      • 13.14.3 Evolution of Business Models & Revenue Streams
      • 13.14.4 AI-Driven Product, Service & Innovation Transformation
      • 13.14.5 Customer Behavior, AI Adoption & Future Market Evolution

  • Chapter 14. TOP 10 Country Analysis

    • 14.1 Country 1
    • 14.2 Country 2
    • 14.3 Country 3
    • 14.4 Country 4
    • 14.5 Country 5
    • 14.6 Country 6
    • 14.7 Country 7
    • 14.8 Country 8
    • 14.9 Country 9
    • 14.10 Country 10

  • Chapter 15. Research Findings

    • 15.1 Key Takeaways
    • 15.2 Analyst Point of View
    • 15.3 Assumptions and Acronyms

  • Chapter 16. Research Methodology and Sources

    • 16.1 Primary Data Collection
      • 16.1.1 Steps for Primary Data Collection
        • 16.1.1.1 Identification of KOL
      • 16.1.2 Backward Integration
      • 16.1.3 Forward Integration
      • 16.1.4 How Primary Research Help Us
      • 16.1.5 Modes of Primary Research
    • 16.2 Secondary Research
      • 16.2.1 How Secondary Research Help Us
      • 16.2.2 Sources of Secondary Research
    • 16.3 Data Validation
      • 16.3.1 Data Triangulation
    • 16.4 Data Representation

Athenaeum AI Dashboard

Research Framework · 70:30 Primary:Secondary

Our Proprietary Methodology

Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Aarti Bagekari and team for the Healthcare Fraud Analytics Market Analysis Market analysis.

01

Primary Intelligence Gathering

Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.

02

Secondary Data Triangulation

Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.

03

Expert Validation Protocol

Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.

04

Athenaeum AI Processing

Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.

05

Editorial & QA Review

Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.

Data Assurance Metrics
Data Points Validated 10,400+
Expert Interviews 54
Countries Covered 39+
Company Profiles 34+
Forecast Accuracy (Historical) 94.2%
Report Pages 250+
Analytical Coverage
Market Sizing Revenue Forecast CAGR Analysis Competitor Benchmarking SWOT Porter's Analysis PESTEL Value Chain ESG Analysis Tariff Impact Patent Mapping Tech Trends

To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.

Sources from the Service & Software Industry

How We Serve You

The Three Pillars of End-to-End Market Research Services

We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Healthcare Fraud Analytics Market Analysis market.

Service 01

Market Survey

B2B B2C

Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the healthcare fraud analytics market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.

What's Included
  • Buyer intent & sentiment analysis
  • Purchase cycle mapping
  • Price sensitivity research
  • Channel preference profiling
  • Competitive perception study
Most Requested
Service 02

Customized Market Data & Reports

Custom Ready Report

Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.

What's Included
  • Ready syndicate report (250+ pages)
  • Custom data scope & segmentation
  • Excel quantitative models
  • Board-ready PPT with key findings
  • Secure cloud portal access
Service 03

Strategic Consultation

With Survey With Report

Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.

What's Included
  • Dedicated analyst assigned to you
  • Live walkthrough of findings
  • Strategic Q&A sessions
  • Go-to-market recommendations
  • NDA-protected engagement

Customize This Report

Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.